retatrutide type 2 diabetes phase 2 trial weight loss 2024 Retatrutide, an experimental weight-loss drug VisualAbstract: Retatrutide reduces body weight

We do not guarantee outcomes but aim to provide context for informed, individualized treatment decisions

Whether the same effect would show up in a generally healthy person trying to lose weight is an open question

Nutrition quality should be prioritized over restriction, especially in patients using GLP-1 therapies

A substudy examining participants with metabolic-associated steatotic liver disease produced results that no pharmacological intervention had previously achieved

Let us help you take the guesswork out of weight lossand make your progress feel possible again

The maximum approved dose is 15 mg once weekly, typically reached by week 20 or 21 of treatment